Mirataz : EPAR - Medicine overview (PDF/118.96 KB)
First published: 08/01/2020
This EPAR was last updated on 08/01/2020
|Agency product number||
|International non-proprietary name (INN) or common name||
|Date of issue of marketing authorisation valid throughout the European Union||
10/12/2019 Mirataz - EMEA/V/C/004733 -
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.